Market Access Services
News, Events & Publications |
 |
Newsletter
Covance Insights newsletter for medical technology marketers:
2nd Quarter 2007
1st Quarter 2007
Events
Join Covance for a free Webcast on the OPPS and ASC Proposed Rules
2007
Publications
Globe D, Glidden D, Hertel J, Thomas J, Ackerman M, Chidolue F, Blanco B, Borden A, Goss T, Xu X, KewalramaniR. Assessment of the impact of weekly versus monthly erythropoiesis stimulating protein therapy on patients with chronic kidney disease and their families. Nephrology Nursing Journal. (In Press)
Hutchison R, Anastassopoulos K, Vallow S, Mordin M, Sikirica V, Olson W, Hewitt D. Intravenous patient controlled analgesia (IV PCA) pump and reservoir logistics: Results from a multicenter questionnaire. Hospital Pharmacy 2007. (In Press)
file:///Volumes/fileserver/PROJECTS/Covance/*html_wkg/web/images/img_mktaccess/mkt_brent.jpg
Lotery A, Xu X, Zlateva G. Burden of illness, visual impairment, and health resource utilisation of patients with neovascularage-related macular degeneration: Results from the United Kingdom cohort of a five-country cross- sectional study. British Journal of Ophthalmology. (Accepted)
Marotta C, Knight T, Scharf J, Mafilios M, Matchar D, Samsa G, Goss T. Cost-effectiveness analysis of usual stroke care vs. novel therapy in acute ischemic stroke patients. Stroke 2007; 38(2):575.
Matchar D, Samsa G, Knight T, Ball J, Marotta C, Goss T. Thrombolytic usage for acute ischemic stroke as reflected in Medicare 2002 and 2004 files: Rates and determinants of use. Stroke 2007; 38(2):459.
Mordin M, Anastassopoulos K, van Breda A, Vallow S, Zhang M, Gargiulo K, Hewitt D, Olson W, Sikirica V. Clinical staff resource use with intravenous patient-controlled analgesia (IV-PCA) in acute postoperative pain management: Results from a multicenter, prospective, observational study. Journal of PeriAnesthesia Nursing. (In Press)
Soubrane G, Cruess A, Lotery A, Pauleikhoff D, Monès J, Xu X, Zlateva G, Buggage R, Conlon J, Goss T. Burden and resource utilization of neovascular AMD: Findings of a multicountry study. Archives of Ophthalmology. (Accepted)
Szende A, Oppe M, Devlin N (Eds.). EQ-5D value sets: Inventory, comparative review and user guide. EuroQolGroup Monographs 2007; 2.
Abstract Presentations
Cruess A, Lotery L, Zlateva G, Buggage R, Xu X. Inter-country difference in the cost of age related macular degeneration: Survey of five countries. The Association for Research in Vision and Ophthalmology (ARVO) 2006 Annual Meeting, Fort Lauderdale, FL, May 6-10, 2007.
Lotery A, Cruess A, Xu X, Zlateva G, Goss T, Knight T. Inter-country differences in patients' perception of humanistic burden of neovascularage-related macular degeneration (AMD). The Association for Research in Vision and Ophthalmology (ARVO) 2006 annual meeting, Fort Lauderdale, FL, May 6-10, 2007.
Marotta C, Knight T, Scharf J, Mafilios M, Matchar D, Samsa G, Goss T. Cost-effectiveness analysis of usual stroke care vs. novel therapy in acute ischemic stroke patients. American Heart Association International Stroke Conference 2007, San Francisco, CA, February 7-9, 2007. (Submitted in collaboration with researchers at Duke University Medical Center)
Matchar D, Samsa G, Knight T, Ball J, Marotta C, Goss, T. Thrombolyticusage for acute ischemic stroke as reflected in Medicare 2002 and 2004 files: Rates and determinants of use. American Heart Association International Stroke Conference 2007, San Francisco, CA, February 7-9, 2007. (Submitted in collaboration with researchers at Duke University Medical Center)
2006
Publications
Bernardo M, Crawford P, Hertel J, Sholer C, Xu X, Goss T, Kewalramani R, Globe D. Assessment of time and practice resources required to provide weekly or monthly erythropoiesis stimulating protein therapy to chronic kidney disease patients in the physician office setting. Journal of Managed Care Pharmacy 2006; 12(9):714-725.
Chidolue F, Glidden D, Blanco B, Xu X, Scharf J, Kewalramani R, Globe D. Comparison of humanistic and economic burden of weekly (QW) versus monthly (QM) erythropoiesis stimulating protein (ESP) therapy for anemia in patients with CKD and their families. Journal of the American Society of Nephrology 2006; 17:622A.
Goss T, Szende A, Schaefer C, Totten J, Knight R, Jädersten M, Hellström-Lindberg E, List A. Cost effectiveness of lenalidomide in the treatment of transfusion-dependent myelodysplastic syndromes in the United States. Cancer Control: Journal of the Moffitt Cancer Center 2006; 13:Supp.
Kallich J, McDermott A, Xu X, Fayers P, CellaD. The relationship between patient knowledge of hemoglobin levels and health-related quality of life. Quality of Life Research 2006; 15:57-68.
McDermott A, Tölle T, Rowbotham D, Schaefer C, Dukes E. The burden of neuropathic pain: Results from a cross-sectional survey. European Journal of Pain 2006 Feb; 10(2):127-135.
Szende A, Schaefer C. A taxonomy of health utility assessment methods and the role for uncertainty analysis. European Journal of Health Economics 2006 Jun; 7(2)147-151.
Thomas J, Ackerman M, Borden A, Xu X, Goss T, Kewalramani R, Globe D. Comparison of practice resource use and patient burden for weekly (QW) compared to monthly (QM) erythropoiesis stimulating protein (ESP) therapy. Journal of the American Society of Nephrology 2006; 17:918A.
Toelle T, Xu X, Sadosky AB. Painful diabetic neuropathy: A cross-sectional survey of health state impairment and treatment patterns. Journal of Diabetes and Its Complications 2006; 20(1):26-33.
Totten Jand Goss T. The impact of payer coverage and reimbursement policies on off-label use of anticancer therapies. Oncology Issues 2006 Jan/Feb; 40-42.
Xu X, Brandenburg N, McDermott A, Bazil C. Sleep disturbances reported by partial-onset epilepsy patients receiving polytherapy. Epilepsia 2006; 47(7):1176-1183.
Xu X, Zlateva G, Goss T, Buggage R, Cruess A. Impact of bilateral neovascularage-related macular degeneration and related visual impairment on patients' quality of life and functioning: A survey of five countries. Value in Health 2006; 9:A371-A372.
Zlateva G, Xu X, Lenz C, Pauleikhoff D. Humanistic burden and health resource utilization among neovascular age-related macular degeneration (AMD) patients: Results for Germany from a multi-country cross-sectional study. Value in Health 2006; 9:A206-A207.
Abstract Presentations
Anderson P, Traynelis V, Ackerman S J, Ross D. Economic analysis of artificial cervical disc replacement versus anterior cervical fusion surgery in the non-elderly: Impact on hospital and societal costs. Cervical Spine Research Society (CSRS) 2006 CSRS European Section Annual Meeting, Berlin, Germany, May 17-20, 2006.
Bernardo M, Mafilios M, Scharf J, Globe D, KewalramaniR. Costs of anemia management in chronic kidney disease (CKD) from the perspective of the payor, patient, and family. American Society of Nephrology 39th Annual Renal Week Meeting, San Diego, CA, November 14-19, 2006.
Bernardo M, Hertel J, Xu X, Siracusa J, Kewalramani R, Globe D. Comparison of practice resources required to provide weekly (QW) versus monthly (QM) erythroiesis stimulating protein (ESP) therapy. National Kidney Foundation (NKF) 2006 Spring Clinical Meetings, Chicago, IL, April 19-23, 2006.
Buggage R, Xu X, Cruess A, Zlateva G, Knight T, Goss T. Clinical characteristics and impact of neovascularage-related macular degeneration on medical status, daily living, functioning, and health resource utilization: A survey of five countries. Association for Research in Vision and Ophthalmology (ARVO) 2006 Annual Meeting, Fort Lauderdale, FL, April 30-May 4, 2006.
Chidolue F, Glidden D, Blanco B, Xu X, Scharf J, Kewalramani R, Globe D. Comparison of humanistic and economic burden of weekly (QW) versus monthly (QM) erythropoiesis stimulating protein (ESP) therapy for anemia in patients with CKD and their families. American Society of Nephrology Renal Week, San Diego, CA, November 14-19, 2006.
Cramer J, Brandenburg N, Vera-Llonch M, Oster G, Xu X. The impact of seizure and adverse effects on global health ratings. First Annual North American Regional Epilepsy Congress, San Diego, CA, December 1-5, 2006.
Crawford P, Sholer C, Xu X, Goss T, Kewalramani R, Globe D. Time associated with in-office erythroieses stimulating protein (ESP) injections for anemia in chronic kidney disease (CKD) patients. National Kidney Foundation 2006 Spring Clinical Meetings, Chicago, IL, April 19-23, 2006.
Cruess A, Xu X, Monès J, Lotery A, Pauleikhoff D, Soubrane G, Zlateva G, Goss T. Humanistic burden and health resource utilization among neovascularage-related macular degeneration (AMD) patients: Results from a multi-country cross-sectional study. Association for Research in Vision and Ophthalmology (ARVO) 2006 Annual Meeting, Fort Lauderdale, FL, April 30-May 4, 2006.
Goss T, Szende A, Schaefer C, Totten J, Wang M, List A. Cost-effectiveness of lenalidomide in the treatment of patients with transfusion-dependent myelodysplastic syndromes (MDS) in the United States. American Society of Clinical Oncology Annual Meeting, Atlanta, GA, June 2-6, 2006.
Hertel J, Crawford P, Mafilios M, Scharf J, Kewalramani R, Globe D. Cost minimization model evaluating resource utilization to nephrology practices treating patients with erythropoiesis stimulating protein (ESP) on a monthly (QM) versus weekly (QW) basis. National Kidney Foundation Spring Clinical Meeting, Chicago, IL, April 19-23, 2006.
Marotta C, Scharf J, Mafilios M, Knight T, Parker D, Samsa G, Goss T. Impact of length of stay and costs on the ability of hospitals to adopt new technology for the treatment of acute ischemic stroke patients. International Stroke Conference, Kissimmee, FL, February 16-18, 2006.
Monès J, Lotery A, Pauleikhoff D, Soubrane G, Cruess A, Zlateva G, Xu X. Humanistic burden and health resource utilization among neovascularage-related macular degeneration (AMD) patients: Results from a multi-country cross-sectional study. The 6th European Society of Retina Specialists (EURETINA) Congress, Lisbon, Portugal, May 18-20, 2006.
Pauleikhoff D, Lotery A, Monès J, Soubrane G, CruessA F, Zlateva G, Xu X, Buggage R. Impact of neovascularage-related macular degeneration on medical status, daily living, and health resource utilization: A survey of five countries. The 6thEuropean Society of Retina Specialists (EURETINA) Congress, Lisbon, Portugal, May 18-20, 2006.
Rubin R J, Glaspy J, Adams J, Mafilios M, Scharf J, Viswanathan H, Kallich J. Cost-minimization analysis of darbepoetin alfa every three weeks versus weekly epoetin alfa initiated at labeled starting doses for the treatment of chemotherapy-induced anemia. American Society of Health System Pharmacists Midyear Clinical Meeting, Anaheim, CA, December 3-7, 2006.
Schaefer C, Szende A, Morgan G, Wang M, Goss T. Cost-effectiveness of lenalidomide in the treatment of relapsed or refractory multiple myeloma(MM) in patients in the United Kingdom. 11th Congress of the European Hematology Association, Amsterdam, The Netherlands, June 15-18, 2006.
Soubrane G, Pauleikhoff D, Cruess A, Lotery A, Monès J, Xu X, Zlateva G, Goss T, Buggage R, Patel M. Humanistic burden and health resource utilization in neovascularage-related macular degeneration (AMD) patients from five countries. American Society of Retina Specialists (ASRS)/European Vitreo Retinal Society (EVRS) Cannes Retina Festival 2006 Meeting, Nice, France, September 9-13, 2006.
Szende A, Schaefer C, Goss T, Wang M, Heptinstall K. Value of transfusion-free living in MDS: Results of health utility interviews with patients. 11th Congress of the European Hematology Association, Amsterdam, The Netherlands, June 15-18, 2006.
Thomas J, Ackerman M, Borden A, Xu X, Goss T, Kewalramani R, Globe D. Resource use associated with routine erythropoiesis stimulating protein (ESP) therapy in outpatient setting: Assessments from the perspective of practices and patients. Kidney Disease Economic Conference (KDEC), Baltimore, M D, October 27-29, 2006.
Thomas J, Ackerman M, Borden A, Xu X, Goss T, Kewalramani R, Globe D. Comparison of practice resource use and patient burden for weekly (QW) compared to monthly (QM) erythropoiesis stimulating protein (ESP) therapy. American Society of Nephrology Renal Week 2006 meeting, San Diego, CA, November 14-19, 2006.
Thompson W R, Ackerman S J, Watrous R L. The impact of computer-assisted auscultation on physician recognition and interpretation of heart murmurs. American Academy of Pediatrics (AAP) National Conference and Exhibition, Atlanta, GA, October 7-10, 2006.
Wang S, Yang W, Nichol M, Dow T, Johnson K. Statin therapy persistence in a managed care population. ISPOR 11th Annual International Meeting, Philadelphia, PA, May 15-18, 2006. Wang Sand Gwadry-Sridhar F. A systematic overview of the measurement properties of the St. George's Respiratory Questionnaire in asthma. ISPOR 11th Annual International Meeting, Philadelphia, PA, May 15-18, 2006.
Xu X, Zlateva G, Goss T, Buggage R, Cruess A. Impact of bilateral neovascularage-related macular degeneration and related visual impairment on patients' quality of life and functioning: A survey of five countries. ISPOR 9th Annual European Congress, Copenhagen, Denmark, October 28-31, 2006.
Zlateva G, Xu X, Lenz C, Pauleikhoff D. Humanistic burden and health resource utilization among neovascularage-related macular degeneration (AMD) patients: Results for Germany from a multi-country cross-sectional study. ISPOR 9th Annual European Congress, Copenhagen, Denmark, October 28-31, 2006.
2005
Publications
Berndt E, Kallich J, McDermott A, Xu X, Lee H, Glaspy J. Reductions in anemia and fatigue are associated with improvements in productivity. Pharmacoeconomics 2005; 23(5):505-514.
Cramer J, Brandenburg N, Xu X. Differentiating anxiety and depression symptoms in patients with partial elipepsy. Epilepsy and Behavior 2005; 6(4):563-569.
Goss T, Mafilios M, Reblando J, Parker G, Marotta C.Summary of medical resource utilization and costs associated with hospital inpatient treatment of acute stroke. Stroke 2005; 36:477.
Szende A, Leidy N, Revicki D. Health-related quality of life and other patient-reported outcomes in the European centralised drug regulatory process: A review of guidance documents and performed authorizations of medicinal products 1995 to 2003. Value in Health 2005; 8:5.
Abstract Presentations
Ackerman S, Anastassopoulos K, Lacey M, Amorosi S, Knight T, Lieberman D. Use of colonoscopy in Medicare beneficiaries increased substantially between 1999 and 2002 while the use of other colorectal cancer diagnostic tests declined. Digestive Disease Week 2005, Chicago, IL, May 14-19, 2005.
Berger J, Anastassopoulos K, Zhang M, Olson W, Hewitt D. Resource utilization associated with intravenous patient-controlled analgesia (IV PCA) in acute postoperative pain management: An interim analysis. American Society of Anesthesiologists 100th Annual Meeting, Atlanta, GA, October 21-25, 2005.
Cramer J, Brandenburg N, Xu X. Differentiating anxiety and depression in epilepsy patients. 2005 American Academy of Neurology Conference, Miami, FL, April 9-16, 2005.
Duff S, Yeh Y, Yu E, Woolley J. The economic impact of etanercept and infliximab treatment in ankylosing spondylitis. Annual European Congress of Rheumatology EULAR 2005, Vienna, Austria, June 8-11, 2005.
Goss T, Mafilios M, Reblando J, Parker D, Marotta C. Medicare reimbursement for acute stroke care is routinely less than providers' costs for treatment of acute stroke. American Heart Association's Internation Stroke Conference, New Orleans, LA, February 2-4, 2005.
Goss T, Szende A, Brueckner J, Wang M, Schaefer C, List A. Cost-effectiveness of lenalidomide in the treatment of patients with transfusion-dependent myelodysplastic syndromes (MDS) in the United States. American Society of Hematology (ASH) Annual Meeting, Atlanta, GA, December 10-13, 2005.
Hamilton J, Mordin M, Zhang M, Olson W, Hewitt D. Logistics of Intravenous Patient-controlled Analgesia in the Treatment of Acute Pain Following Orthopedic or Gynecologic Surgery. American Society of Anesthesiologists 100th Annual Meeting, Atlanta, GA, October 21-25, 2005.
Hutchison R, Mordin M, Albright Y, Zhang M, Vallow S. Hospital Resources Associated With Intravenous Patient-controlled Analgesia in the Management of Acute Pain Following Orthopedic or Gynecologic Surgery. American Society of Health-System Pharmacists Midyear Clinical Meeting, Las Vegas, NV, December 2005.
Jones A, Ackerman S, Knight T, Duff S. Costs versus reimbursement for treatment of open tibia fracture in a California Medicaid population. Scientific Program of the 72nd Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), Washington, DC, February 23-27, 2005.
Lieberman D, Lacey M, Anastassopoulos K, Amorosi S, Knight T, Ackerman S. Medicare colonoscopy rates among gastroenterologists between 1999 and 2002: Are gastroenterologists at capacity for colonoscopy in Medicare beneficiaries? Digestive Disease Week 2005, Chicago, IL, May 14-19, 2005.
Mordin M, Gordon D, Anastassopoulos K, van Bretta A, Richardson D, Goss T, Olson W, Hewitt D, and Zhang M. A multicenter, prospective, observational study of intravenous patient-controlled analgesia (IV-PCA) resource utilization (RU) in acute postoperative pain management. American Society of Health-System Pharmacists Annual Meeting, Boston, M A, June 11-15, 2005.
Peloza J, Anastassopoulos K, Dunham M, Ackerman S.Use of rhBMP-2 versus AICBG in treatment of lumbar spine degenerative disc disease and spondylolisthesis: Do rhBMP-2 patients return to work sooner? North American Spine Society (NASS) 20th Annual Meeting, Philadelphia, PA, September 27-October 1, 2005.
Szende A, Wang M, Husbands C, Schaefer C, Goss T. Disease state and quality of life in patients with myelodysplastic syndromes: A review of instruments, disease burden, and predictive factors for outcomes. 10th Anniversary Congress of the European Hematology Association, Stockholm, Sweden, June 2-5, 2005.
Szende A, Husbands C, Wang M, Schaefer C, Goss T. Disease state and quality of life in patients with myelodysplastic syndromes: A review of instruments, disease burden, and predictive factors for outcomes. ISPOR 8th Annual European Congress, Florence, Italy, November 6-8, 2005.
Yeh Y, Schaefer C, Kutikova L, Edgell E, Husbands C, Szende A. Quality of life (QOL) in hepatocellular carcinoma (HCC): A review of instruments, disease burden, and QOL outcomes. International Society for Quality of Life Research (ISOQOL) 12th Annual Scientific Conference, San Francisco, CA, October 19-22, 2005.
Zhang M, Anastassopoulos K, Hutchison R, Olson W, Goss T, Hewitt D, Gargiulo K, Siccardi M, Mordin M. Summary of hospital logistics associated with intravenous patient-controlled analgesia (IV-PCA) for acute postoperative pain management. International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 10th Annual International Meeting, Washington, DC, May 15-18, 2005.
2004
Publications
Ackerman S, Knight T, Schein J, Carter C, Staats P. Risk of constipation in patients prescribed fentanyl transdermal system or oxycodone hydrochloride controlled-release in a California Medicaid population. The Consultant Pharmacist 2004; 19:118-132.
Cella D, Kallich J, McDermott A, Xu X. The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: Results from five randomized clinical trials. Annals of Oncology 2004; 15:979-986.
Abstract Presentations
Jones A, Swiontkowski M, Polly D, Duff S, Ackerman S. Use of rhBMP-2 in the treatment of open tibialshaft fractures: Do improved clinical outcomes outweigh the additional expense of rhBMP-2? Orthopaedic Trauma Association (OTA) 20th Annual Meeting, Fort Lauderdale, FL, October 8-10, 2004.
McDermott A, Tölle T, Rowbotham D, Schaefer C, Dukes, E. Pain severity, functioning, and health resource utilization among neuropathic pain patients: Results from a cross-sectional survey. 3rd World Congress, World Institute of Pain (WIP), Barcelona, Spain, September 21-25, 2004.
Schmidt R, Ackerman S, Newstead G, Quam J, Mordin M, Anastassopoulos K, Nishikawa R. Comparative feature analysis of computed radiography for mammography (CRM) soft copy display vs. CRM hard copy film: An observer performance study. Radiological Society of North America (RSNA) 90th Scientific Assembly & Annual Meeting, Chicago, IL, November 28-December 3, 2004.
2003
Publications
Ackerman S, Mordin M, Reblando J,Xu X, Schein J, Vallow S, Brennan M. Patient-reported utilization patterns of fentanyl transdermal system and oxycodone hydrochloride controlled-release among patients with chronic nonmalignant pain. Journal of Managed Care Pharmacy 2003; 9:223-231.
Barron R, Carlsen J, Duff S, Burk C. Estimating the cost of an emergency room visit for migraine headache. Journal of Medical Economics 2003; 6:43-53.
Beusterien K, Ackerman S, Plante K, Glaspy J, Naredi P, Wood D, Gehlsen K, Zeger S, AgarwalaS. The health-related quality of life impact of histamine dihydrochloride plus interleukin-2 compared to interleukin-2 alone in patients with metastaticmelanoma. Supportive Care in Cancer 2003; 11:304-312. Published online: 28 January 2003. DOI 10.1007/s00520-002-0419-3.
Damiano A,Siddique R, Xu X, Johanson J, SloanS. Reductions in symptom distress reported by patients with moderately-severe, nonerosive gastroesophageal reflux disease treated with rabeprazole. Digestive Diseases and Sciences 2003; 44(4):657-662.
Diestelhorst M, Schaefer C, Beusterien K, Plante K, Fain J, Mozaffari E, Dhawan R. Persistency and clinical outcomes associated with latanoprost and beta-blocker monotherapy: Evidence from a European retrospective cohort study. European Journal of Ophthalmology 2003; 13(Suppl. 4):S21-S29.
Duff S, Scott E, Mafilios M, Todd E, Krilov L, Geddes A, Ackerman S. Cost-effectiveness of a targeted disinfection program in household kitchens to prevent foodborne illnesses in the United States, Canada, and the United Kingdom. Journal of Food Protection 2003; 66:203-2115.
Ellis C, Mordin M,Adler E. Effects of alefacepton health-related quality of life in patients with psoriasis: Results from a randomized, placebo-controlled phase II trial. American Journal of Clinical Dermatology 2003; 4(2):131-139.
Polly D, Ackerman S, Shaffrey C, Wang J, Stralka S, Mafilios M, Ogilvie J, Heim S, SandhuH. A cost analysis of bone morphogenetic protein versus autogenousiliac crest bone graft in single-level anterior lumbar fusion. Orthopedics 2003; 26:1027-1037.
Tchekmedyian N, Kallich J, McDermott A, Fayers P, and ErderM. The relationship between psychological distress and cancer-related fatigue. Cancer 2003; 98:198-203.
Abstract Presentations
Ackerman S, Knight T, Schein J, StaatsP. Risk of constipation in patients prescribed fentanyl transdermal system or oxycodone controlled-release in a California Medicaid population. American Geriatrics Society (AGS) Annual Scientific Meeting, Baltimore, MD, May 14-18, 2003.
Cangialose C, Yeh Y, Pelham R W, Nolan C R, and QunibiWY. The economics of phosphate binders in renal dialysis: A two-stage strategy for managing hyperphosphatemia. 8th International Meeting of ISPO R, Arlington, VA, May 19, 2003.
Diette G, Cangialose C, Knight T, Yeh Y, Goss T, Harnett J, Wilson J. Long-term benefits of antibiotic treatment in reducing recurrence rates and resource utilization in acute exacerbations of chronic bronchitis. European Respiratory Society (ERS) Congress, Vienna, Austria, September 27-October 1, 2003.
Duff S, Mafilios M, Scott E, Todd E, Krilov L, Geddes A, Ackerman S. The cost-effectiveness of a program to prevent foodborne illnesses in the household setting. International Association of Food Protection (IAFP) Annual Meeting, New Orleans, LA, August 10-13, 2003.
Duff S,Carlsen J, Barron R, Ravelo A, Burk C. Estimating the cost of an emergency room visit for migraine headache. 25th Annual Meeting of the Society for Medical Decision Making, Chicago, IL, October 18-22, 2003.
Kallich J, Xu X, McDermott A, Erder M, Cella D. Reducing anemia-related fatigue improves health-related quality of life in anemic cancer patients: Results from five randomized trials. Annual Meeting of the International Society of Quality of Life Research, Prague, Czech Republic, November 12-15, 2003.
Mehta J, Duff S, Gupta S. Bortezomibis cost-effective for the treatment of relapsed and refractory multiple myeloma. Blood 2003; 102(11):500a-501a. 45th Annual Meeting of the American Society of Hematology, San Diego, CA, December 6-9, 2003.
Polly D, Ackerman S, Shaffrey C, Wang J, Stralka S, Mafilios M, Ogilvie J, Heim S, SandhuH. An economic analysis of BMP for fusion. World Spine II: Second Interdisciplinary Congress on Spine Care, Chicago, IL, August 10-13, 2003.
Polly D, Mafilios M, Ackerman S, Burkus K. An updated cost analysis of BMP in spinal fusion. North American Spine Society 18th Annual Meeting, San Diego, CA, October 21-25, 2003.
Quam J, Ackerman S, Mordin M, Bassett L. Conspicuity and characterization of findings on computed radiography for mammography vs. screen-film mammography: Results from a prospective clinical trial. 89th Annual Meeting of the Radiological Society of North America, Chicago, IL, December 2, 2003.
Qunibi W, Pelham R, Yeh Y, Cangialose C. Phosphate Binder Economics and Morbidity: An Examination of Renagel® and Phoslo®. National Kidney Foundation Annual Clinical Meeting, Dallas, TX, April 2-6, 2003.
Schwartz G, Schaefer C, Yeh Y, Nordin J. Clinical and economic outcomes of latanoprost, bimatoprost, or travoprost therapy in glaucoma patients: A three-month retrospective study. American Glaucoma Society Annual Meeting, San Francisco, CA, March 6-9, 2003.
Schwartz G, Schaefer C, Yeh Y, Nordin J, Mozaffari E. Clinical and economic outcomes of latanoprost, bimatoprost, or travoprost therapy in glaucoma patients: A three-month retrospective study. 4th International Glaucoma Symposium, Barcelona, Spain, March 19-22, 2003.
2002
Publications
Ackerman S, Mafilios M, Polly D. Economic evaluation of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level interior lumbar fusion: An evidence-based modeling approach. Spine 2002; 27(16S):S94-S99.
Beusterien K, Plante K, Waksman R, Raizner A, Annis M, Goss T. The cost effectiveness of beta-radiation therapy for treatment of in-stentrestenosis: An analysis at 290 days follow-up. Cardiovascular Radiation Medicine 2002; 3(2):107-113.
Damiano A, Handley K, Adler E, Siddique R, Bhattacharyja A. Measuring symptom distress and health-related quality of life in clinical trials of gastroesophageal reflux disease: further validation of the gastroesophageal reflux disease symptom assessment scale (GSAS). Digestive Diseases and Sciences 2002; 47:1530-1537.
Duff S, Mordin M. Strategies for assessing health economic and quality of life outcomes in multiple sclerosis. Expert Review of Pharmacoeconomics and Outcomes Research 2002; 2(6):577-587.
Johanson J, Siddique R, Damiano A, Jokubaitis L, Murthy A, Bhattacharjya A. Rabeprazoleim proves health-related quality of life in patients with erosive gastroesophageal reflux disease. Digestive Diseases and Sciences 2002; 47(11):2574-2578.
Kanter L, Siegel C, Snyder C, Pelletier E, Buchner D, Goss T. Impact of respiratory symptoms on health-related quality of life and medical resource utilization of patients treated by allergy specialists and primary care providers. Annals of Allergy Asthma and Immunology 2002; 89:139-147.
Kallich J, Tchekmedyian N, Damiano A, Shi J, Black J, Erder M. Psychological outcomes associated with anemia-related fatigue in cancer patients. Oncology 2002; 16(9, Suppl.):117-124.
Luthi J, McClellan W, Fitzgerald D, Krumholz H, Delaney R, Bratzler D, Elward K, Cangialose C, Ballard D. Mortality associated with the quality of care of patients hospitalized with congestive heart failure. International Journal of Quality in Health Care 2002; 14(1):15-24.
Malkin J, Ackerman S, Schein J, Thornhill J, Ashburn M. Prescribing patterns for fentanyl transdermal system and oxycodone hydrochloride controlled-release in a California Medicaid population. Journal of Managed Care Pharmacy 2002; 8:132-140.
Steinberg J, Beusterien K, Plante K, Nordin J, Chaikoff E, Arcona S, Kim J, Belletti D. A cost analysis of living skin equivalent in the treatment of diabetic foot ulcers. Wounds. 2002; 14(4):142-149.
Abstract Presentations
Agarwala S, O'Day S, Whitman E, Ackerman S, Plante K, Beusterien K, Gehlsen K, Glaspy J. The health-related quality of life impact of histamine dihydrochloride plus interleukin-2 compared to interleukin-2 alone in patients with metastatic melanoma. European Society for Medical Oncology (ESMO) Congress, Nice, France, October 18-22, 2002.
Damiano A, Siddique R, Xu X, Imeokparia A. Factor structure and further validation of the gastroesophageal reflux disease (GERD) symptom assessment scale. Value in Health 2002; 5:254. 7th annual International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Arlington, V A, May 19-22, 2002.
Grogg A, Damiano A, Malkin J, Sadik K. Change in bipolar disorder payer costs after treatment with risperidone and olanzapine: Analysis of Medicaid claim data. 23rd Collegium Internationale Neuro-Psychopharmacologium(CINP) Congress, Montreal, Canada, June 23-27, 2002.
Menter A, Gottlieb A, Griffiths C, Rizova E, Mordin M. Health-related quality of life impact of weekly intravenous or intramuscular Alefacept™ in patients with chronic plaque psoriasis: results from two randomized, placebo-controlled phase III studies. Annual Meeting of the American Academy of Dermatology, New Orleans, LA, February 22-27, 2002.
Polly D, Ackerman S, Shaffrey C, Wang J, Stralka S, Mafilios M, Ogilvie J, Heim S, Sandhu H. An economic analysis of BMP for fusion. North American Spine Society (NASS) 17th Annual Meeting, Montreal, Canada, October 29-November 2, 2002. [2002 Outstanding Poster Award]
2001
Publications
Ackerman S, Duff S, Dennehy P, Mafilios M, KrilovL. Economic impact of an infection control education program in a specialized preschool setting. Pediatrics 2001; 108(6):E102. URL: http://www.pediatrics.org/cgi/content/full/108/6/e102.
Beusterien K, Hill M, Ackerman S, Zacker C. 2001. The impact of Pamidronate on inpatient and outpatient services among metastatic breast cancer patients. Supportive Care in Cancer 2001; 9:169-176.
Buchner D, Graboys T, Johnson K, Mordin M, Goodman L, Partsch D, Goss T. Development and validation of
the ITG health-related quality of life short-form measure for use in patients with coronary artery disease. Clinical Cardiology 2001; 24:556-563.
Mancill C. New APC requirements call for additional compliance procedures. Journal of Health Care
Compliance 2001; 3:42-46.
Mancill C, Levy-Zuckerman P. Pharmacoeconomics of cancer care: Encouraging appropriate patient access to
novel therapies. Audiotape Chapter. New York: Cortlandt Group 2001.
2000
Publications
Ackerman S, Klumpp T, Guzman G, Herman J, Gaughan J, Bleecker G, ManganK. Economic consequences of alterations in platelet transfusion dose: Analysis of a prospective, randomized, double-blind trial. Transfusion 2000; 40:1457-1462.
Ackerman S, Rein A, Blute M, Beusterien K, Sullivan E, Tanio C, Manyak M, Strauss M. Cost-effectiveness of
microwave thermotherapy in patients with benign prostatic hyperplasia: Part I -Methods. Urology 2000; 56:972-
980.
Beusterien K, Buesching D, Robinson R, Keats M, Tomlinson J, Cofran K, Bailit H, Adler D, Bungay K,
Schrammel P, Goss T. Evaluation of an information exchange program for primary care patients with
depression. Disease Management 2000; 3(1):1-9.
Blute M, Ackerman S, Rein A, Beusterien K, Sullivan E, Tanio C, Strauss M, Manyak M. Cost-effectiveness of
microwave thermotherapy in patients with benign prostatic hyperplasia: Part II -Results. Urology 2000; 56:981-987.
Bukstein D, McGrath M, Buchner D, Landgraf J, Goss T. Evaluation of a short-form for measuring health-
related quality of life among pediatric asthma patients. The Journal of Allergy and Clinical Immunology 2000;
105(2):245-251.
Calkins H, Bigger J, Ackerman S, Duff S, Wilber D, Kerr R, Bar-Din M, Beusterien K, Strauss M. Cost-
effectiveness of catheter ablation in patients with ventricular tachycardia. Circulation 2000; 101:280-288.
Damiano A, McGrath M, Willian M, Snyder C, LeWit P, Reyes P, Richter R, Means E. Evaluation of a
measurement strategy for Parkinson's disease: Assessing patient health-related quality-of-life. Quality of Life
Research 2000; 9(1):87-100.
Duff S, Mafilios M, Ackerman S. Economic evaluation of infection control practices in day care and the home:
Methodological challenges and proposed solutions. Pediatric Infectious Disease Journal 2000; 19:S125-S128.
Mancill, C. Preparing for intensified HCFA oversight of partial hospitalization. Journal of Health Care
Compliance 2000; 1:46-55.
Najib M, Stein G, Goss T. Cost-effectiveness of sparfloxacin compared with other oral antimicrobials in
outpatient treatment of community-acquired pneumonia. Pharmacotherapy 2000; 20(4):461-469.
Back to Top |
|
|
